Business Responsibility and Sustainability Reporting (BRSR) of the Company for the FY 2023-24. Mayur Uniquoters Notice For Convening The 31St Annual General Meeting Of The Company For The FY Ended On ...

Mayur Ian Somaiya, Chief Financial Officer of NewAmsterdam Pharma Co N.V. (NASDAQ:NAMS), a $2.24 billion market cap pharmaceutical company, recently executed several transactions involving the ...